Toxicity of L‐ascorbic acid to L929 fibroblast cultures: Relevance to biocompatibility testing of materials for use in wound management
- 1 April 1993
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 27 (4) , 521-530
Abstract
Fibroblast cultures are often used to evaluate materials intended for medical use, cytotoxicity being taken as an indicator of bioincompatibility. Such an approach has previously been taken with ascorbic acid in determining its value in wound healing. We have now reexamined the toxicity of L‐ascorbic acid to L929 fibroblast cells in culture. Concentrations of ascorbic acid between 0.5 mM and 11 mM were tested. At concentrations above 2 mM, ascorbic acid was found to inhibit cell proliferation, with cell viability decreasing as the concentration was increased. This effect could be prevented by the addition of either superoxide dismutase or catalase to the culture medium. Assays of glutathione and glutathione disulfide were carried out on 8 day old cultures exposed for 24 h to the same concentrations of ascorbic acid. A dose‐related depletion of glutathione occurred whilst glutathione disulfide levels remained essentially constant. Lactate dehydrogenase and glucose‐6‐phosphate dehydrogenase activities were induced by ascorbic acid at all concentrations tested but the ratio of NADP to NADPH nevertheless increased as the concentration of ascorbic acid increased. Finally, ATP in cells from 8‐day‐old cultures became depleted in the presence of ascorbic acid at concentrations in excess of about 5 mM when assayed after 24 h incubation. These biochemical changes and the concomitant cytostatic/cytotoxic effects may be ascribed to the reactive oxygen species produced by the autoxidation of ascorbic acid in the culture medium. Ascorbic acid breakdown products appeared not to be directly involved. In addition, our results suggested that superoxide acted cooperatively with hydroxyl to elicit these effects on the fibroblasts. It is evident from this study that the microenvironment surrounding fibroblasts in culture may differ fundamentally from that surrounding fibroblasts in a healing wound, making it impossible to extrapolate directly to an in vivo situation and hence to make any recommendations from these results concerning the use of ascorbic acid in wound healing. © 1993 John Wiley & Sons, Inc.Keywords
This publication has 35 references indexed in Scilit:
- Cytotoxicity testing of wound dressings using normal human keratinocytes in cultureJournal of Biomedical Materials Research, 1990
- Biocompatibility of wound management products: the effect of various monosaccharides on L929 and 2002 fibroblast cells in cultureJournal of Pharmacy and Pharmacology, 1989
- Biocompatibility of Wound Management Products: Standardization of and Determination of Cell Growth Rate in L929 Fibroblast CulturesJournal of Pharmacy and Pharmacology, 1989
- Selective oxidation of mitochondrial glutathione in cultured rat adrenal cells and its relation to polycyclic aromatic hydrocarbon-induced cytotoxicityArchives of Biochemistry and Biophysics, 1989
- Use of fibroblast cell culture for the study of wound healing drugsInternational Journal of Cosmetic Science, 1984
- Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells,Journal of Cellular Physiology, 1978
- Determination of L-ascorbic acid levels in culture medium: Concentrations in commercial media and maintenance of levels under conditions of organ cultureIn Vitro Cellular & Developmental Biology - Plant, 1977
- Cytotoxicity of ascorbate and other reducing agents towards cultured fibroblasts as a result of hydrogen peroxide formationJournal of Cellular Physiology, 1977
- Glucose-6-phosphate Dehydrogenase1974
- The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblastsArchives of Biochemistry and Biophysics, 1972